Gates Package — page 224
of 1375 pages
← p.223 p.225 → · this page in the original PDF · package
G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023
Reference# I Agreement Type
Effective Date Expiration Dz External Parties
*Lead Pl
2019-0064
Research Collaboration Agreement
4/30/2019}
4/30/2022|BostonGene
Ronald Germain
2019-0069
Gift
4/18/2019}
4/18/2020]Creutzfeldt-Jakob Disease (CJD) Foundation, Inc.
Cathryn Haigh
2019-0099
CRADA
8/20/2020}
8/20/2024|Regeneron Pharmaceuticals, Inc.
Michael Lenardo
2019-0103
Research Collaboration Agreement
8/16/2019]
8/16/2024|Marmara University
Michael Lenardo
Coalition for Epidemic Preparedness Innovations
2019-0149
CRADA
9/13/2019]
_9/13/2022](CEPI), CureVac AG [DE]
Vincent Munster
Coalition for Epidemic Preparedness Innovations
2019-0151
CRADA
5/14/2019]
5/14/2023}(CEPI), Inovio Pharmaceuticals, Inc.
Heinrich Feldmann
Pasteur Institute of Dakar (Institut Pasteur-Dakar)
2019-0159
Research Collaboration Agreement
5/7/2019
[SN]
Patrick Duffy
2019-0168
Research Collaboration Agreement
5/29/2019]
4/29/2021]|SutroVax, Inc.
Harlan Caldwell
2019-0171
Gift
5/23/2019]
9/30/2020] PATH Malaria Vaccine Initiative (MVI) [US]
Patrick Duffy
2019-0186
Research Collaboration Agreement
5/13/2019]
5/13/2020|Johnson C. Smith University
Thomas Wellems
2019-0220
Gift
5/10/2019]
10/31/2020] Bill & Melinda Gates Foundation (BMGF)
2019-0220
Gift
5/10/2019}
10/31/2020 I Bill & Melinda Gates Foundation (BMGF)
2019-0226
Gift
9/18/2019}
12/1/2021] University of Notre Dame [US]
Vincent Munster
2019-0227
CRADA
6/25/2020}
6/25/2024]|F2G Ltd. [GB]
Steven Holland
2019-0235
CTA - Clinical Trial Agreement
5/17/2019
Sanaria, Inc. (see also Protein Potential)
Patrick Duffy
2019-0236
CTA - Clinical Trial Agreement
6/11/2019
Sanaria, Inc. (see also Protein Potential)
Patrick Duffy
2019-0236
CTA - Clinical Trial Agreement
6/11/2019|
Sanaria, Inc. (see also Protein Potential)
Patrick Duffy
2019-0242
CTA - Clinical Trial Agreement
3/12/2019
Biogen, Inc. [US]
Peter Williamson
2019-0245
CRADA
4/2/2019
4/2/2024] Matinas BioPharma Holding, Inc.
Peter Williamson
2019-0260
Research Collaboration Agreement
10/17/2019]
10/17/2021] Wistar Institute
Mark Connors
Maferinyah National Center for Training and
Research in Rural Health (Centre Nat, PATH Malaria
Vaccine Initiative (MVI) [US], Radboud University
Medical Center, State Serum Institute (Statens
Serum Institut, National Serum Institute; SSI) [D,
The National Public Health Institute of Liberia
(NPHIL) [LR], University Sciences Techniques &
2019-0264
Research Collaboration Agreement
8/8/2019)
Technologies of Bamako (USTTB) [ML]
Patrick Duffy
2019-0282
Gift
9/11/2019]
12/31/2023 I Bill & Melinda Gates Foundation (BMGF)
Mathew Memoli
2019-0294
Research Collaboration Agreement
5/15/2019]
5/15/2021] ABCAM PLC [GB]
Thomas Leto
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/224
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00117 | — | attachment | 224 |